GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,133,000 | -19.7% | 187,150 | -18.4% | 0.67% | -13.5% |
| Q4 2021 | $10,122,000 | +25.5% | 229,261 | +8.6% | 0.77% | +26.4% |
| Q3 2021 | $8,065,000 | -4.6% | 211,032 | -0.6% | 0.61% | +9.7% |
| Q2 2021 | $8,455,000 | -4.2% | 212,241 | -14.2% | 0.56% | -13.1% |
| Q1 2021 | $8,828,000 | +15.3% | 247,253 | +18.9% | 0.64% | +9.2% |
| Q4 2020 | $7,657,000 | -11.5% | 207,865 | -9.5% | 0.59% | -8.9% |
| Q3 2020 | $8,650,000 | -9.8% | 229,661 | -2.3% | 0.64% | -12.3% |
| Q2 2020 | $9,591,000 | -23.6% | 235,066 | -28.9% | 0.73% | -36.8% |
| Q1 2020 | $12,548,000 | -27.8% | 330,418 | -10.6% | 1.16% | -8.3% |
| Q4 2019 | $17,384,000 | +10.4% | 369,504 | +0.3% | 1.26% | -5.2% |
| Q3 2019 | $15,746,000 | -37.9% | 368,563 | -41.7% | 1.34% | -31.4% |
| Q2 2019 | $25,361,000 | -44.0% | 632,627 | -41.6% | 1.95% | -39.1% |
| Q1 2019 | $45,271,000 | +2.0% | 1,082,406 | -4.7% | 3.20% | -3.3% |
| Q4 2018 | $44,372,000 | – | 1,135,659 | – | 3.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |